PL387984A1 - Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych - Google Patents

Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych

Info

Publication number
PL387984A1
PL387984A1 PL387984A PL38798409A PL387984A1 PL 387984 A1 PL387984 A1 PL 387984A1 PL 387984 A PL387984 A PL 387984A PL 38798409 A PL38798409 A PL 38798409A PL 387984 A1 PL387984 A1 PL 387984A1
Authority
PL
Poland
Prior art keywords
treatment
new compositions
medicinal substances
chronic pains
pains
Prior art date
Application number
PL387984A
Other languages
English (en)
Inventor
Andrzej W. Lipkowski
Jerzy Jarosz
Original Assignee
Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan filed Critical Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan
Priority to PL387984A priority Critical patent/PL387984A1/pl
Priority to PCT/PL2010/050016 priority patent/WO2010128873A1/en
Publication of PL387984A1 publication Critical patent/PL387984A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL387984A 2009-05-07 2009-05-07 Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych PL387984A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL387984A PL387984A1 (pl) 2009-05-07 2009-05-07 Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych
PCT/PL2010/050016 WO2010128873A1 (en) 2009-05-07 2010-05-07 Combination of an opioid analgesic and an n-type calcium channel blocker for treating chronic pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL387984A PL387984A1 (pl) 2009-05-07 2009-05-07 Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych

Publications (1)

Publication Number Publication Date
PL387984A1 true PL387984A1 (pl) 2010-11-08

Family

ID=42734615

Family Applications (1)

Application Number Title Priority Date Filing Date
PL387984A PL387984A1 (pl) 2009-05-07 2009-05-07 Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych

Country Status (2)

Country Link
PL (1) PL387984A1 (pl)
WO (1) WO2010128873A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19641576C1 (de) * 1996-10-09 1998-05-07 Gruenenthal Gmbh Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten
EP1689401A1 (en) * 2003-10-02 2006-08-16 Elan Pharmaceuticals, Inc. Method for reducing pain
JP2008534630A (ja) * 2005-04-08 2008-08-28 ニューロメッド ファーマシューティカルズ リミテッド 疼痛の軽減のためのｎ型カルシウムチャネルブロッカーを含む組み合わせ治療の方法

Also Published As

Publication number Publication date
WO2010128873A1 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
IL219073A (en) A drug combination for cancer treatment
PT2482812T (pt) Composições farmacêuticas compreendendo bi-1356 e metformina
HK1175398A1 (en) Pharmaceutical composition for treatment of increased intraocular pressure
PL2740796T3 (pl) Kompozycja farmaceutyczna do leczenia nowotworu i/lub zapobiegania nowotworowi
PL2532365T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi
PL2532743T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka
PL2740794T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub profilaktyki nowotworów
IL217901A0 (en) Treatment of bdnf-related disorders using laquninimod
EP2528603A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS
HK1215787A1 (zh) 用於治療疼痛的藥物組合
ZA201201802B (en) Composition for treatment of cxcl8-mediated lung inflammation
IL231622B (en) A pharmaceutical preparation for the treatment of stubbornness
EP2213303A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
EP2465512A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING PAIN
IL215695A (en) Use of Compounds 1-Phenyl-3-Dimethyl Amino Propane for the preparation of rheumatic pain medication
GB201012926D0 (en) Compounds for treatment of inflammation
IL200753A (en) Pharmaceutical preparation containing ib – meca for the treatment of psoriasis
ZA201202379B (en) Antagonists of dsgs2 for treatment of cancer
HK1156250A1 (en) Unit dosage of apadenoson
EP2402342A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING TYPE 2 DIABETES
PL387984A1 (pl) Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych
IL215854A0 (en) Pharmaceutical compositions for the treatment of nasal polyposis
EP2329824A4 (en) NEW PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NOZIZEPTIVE PAIN
IL219050A0 (en) Pharmaceutical composition for the treatment of bladder disorders
HUP1100534A2 (en) Pharmaceutical composition for the treatment of muscle atrophy